Novacyt S.A. (EPA:ALNOV)
France · Delayed Price · Currency is EUR 0.5310
+0.0410 (8.37%)
Aug 21, 2026, 5:35 PM CET
Novacyt Market Cap
Novacyt has a market cap or net worth of €38.5 million as of August 21, 2026. Its market cap has increased by 16.66% in one year.
Market Cap
38.50M
Enterprise Value
28.39M
Revenue
22.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.53
ChartMarket Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 38.50M, an increase of 63.44%. That is a compound annual growth rate of 3.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 38.50M | 39.64% |
| Dec 31, 2025 | 27.57M | -35.08% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carvolix | 359.02M |
| Eurobio Scientific Société anonyme | 200.36M |
| Median Technologies | 178.61M |
| Guerbet | 99.66M |
| Theraclion | 47.30M |
| Mauna Kea Technologies | 30.39M |
| Diagnostic Medical Systems | 27.08M |
| Implanet | 26.58M |